Exciting results regarding new possible drug leads for Alzheimer’s
We have had some exciting results regarding new possible drug leads for Alzheimer’s. We hope to be submitting these soon for publication.
Read moreCategory: Neurological diseases
Applying the drug design methods used in Alzheimer’s to HD
We have also started to apply the drug design methods used in Alzheimer’s to HD.
Read morePresenting the results on HD at a variety of Stanford internal conferences and meetings
Prof. Pande has presented the results on HD at a variety of Stanford internal conferences and meetings. People have been excited and interested in the results.
Read morePresented our results regarding new possible drugs (small molecule leads) to fight Alzheimer’s Disease
We presented our results regarding new possible drugs (small molecule leads) to fight Alzheimer’s Disease at a recent meeting at Stanford, supported by the NIH Roadmap Nanomedicine center and NIH…
Read moreThe first of the papers has come out
The first of the papers has come out (see paper #58 on our Results page: “Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach”). In many…
Read moreCollaboration with Judith Frydman’s group to computationally test a new hypothesis
Nick Kelley has been working on a new collaboration with Judith Frydman’s group to computationally test a new hypothesis for HD aggregation found in the Frydman lab.
Read moreSignificant progress experimentally testing computational predictions
We have made some significant progress experimentally testing our computational predictions using nuclear magnetic resonance spectroscopy (NMR).
Read moreSubmitting first paper
We are currently in the process of submitting our first paper on FAH results.
Read moreFirst paper submitted for peer review
We have submitted our first paper for peer review and we’re working on the next 2 paper right now. We’re very excited about the results!
Read moreProf. Vijay Pande presented recent FAH work
Prof. Vijay Pande presented recent FAH work on AD at the National Parkinson’s Foundation conference.
Read more